Summary
In a prospective study the efficacy of two regimens for selective decontamination of the digestive tract was studied in patients with acute leukaemia during remission induction therapy. Seventy-eight patients were randomized to receive either a combination of cotrimoxazole, polymyxin B and nystatin (group A) or a combination of nalidixic acid, polymyxin B, neomycin and nystatin. With both regimens the gastrointestinal tract could be decontaminated equally effectively from potential pathogens. In the oropharyngeal region the decontamination from Enterobacteriaceae was significantly better in group A (P<0.01). In both groups less than 10% of the acquired infections were caused by gram-negative bacilli and no gram-negative septicaemia occurred in either group. The median time interval until the first acquired infection was 17 days in group A and 36 days in group B, respectively (P<0.05). It is concluded that regimen A might be more effective than regimen B though both regimens prevent reliably severe gram-negative infections.
Similar content being viewed by others
References
Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ (1976) Causes of death in adults with acute leukemia. Medicine 55:259–268
Singer C, Kaplan MH, Armstrong D (1977) Bacteremia and fungemia complicating neoplastic disease. Am J Med 62:731–742
Tobias JS, Wrigley PFM, O'Grady F (1978) Bacterial infections and acute myeloblastic leukaemia: an analysis of two hundred patients undergoing intensive remission induction therapy. Eur J Cancer 14:383–391
Schimpff SC, Young VM, Greene WH, Vermeulen GD, Moody MR, Wiernik PH (1972) Origin of infection in acute nonlymphocytic leukemia. Ann Intern Med 77:707–714
Bodey GP, Rodriguez V, Chang HY, Narboni G (1978) Fever and infection in leukemia patients. Cancer 41:1610–1622
Levine AS, Siegel SE, Schreiber AD, Hauser J, Preisler H, Goldstein JM, Seidler F, Simon R, Perry S, Bennett JE, Henderson ES (1973) Protected environments and prophylactic antibiotics. — A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med 288:477–483
Yates JW, Holland JF (1973) A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer 32:1490–1498
Klastersky J, Debusscher L, Weerts D, Daneau D (1973) Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains. Path Biol 22:5–12
Schimpff SC, Greene WH, Young VM, Fortner CL, Jepsen L, Cusack N, Block JB, Wicrnik PH (1975) Infection prevention in acute nonlymphocytic leukemia: laminar air flow room reverse isolation with oral nonabsorbable antibiotic prophylaxis. Ann Intern Med 82:351–358
Dietrich M, Gaus W, Vossen J, van der Waaij D, Wendt F (1977) Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. I. Clinical results. Infection 5:107–114
Ribas-Mundo M, Granena A, Rozman C (1981) Evaluation of a protective environment in the management of granulocytopenic patients. Cancer 48:419–429
van der Waaij D, Berghuis-de Vries JM (1974) Selective elimination of enterobacteriaceae species from the digestive tract in mice and monkeys. J Hyg (Camb) 72:205–211
van der Waaij D (1979) The colonization resistance of the digestive tract in experimental animals and its consequences for infection prevention, acquisition of new bacteria and prevention of spread of bacteria between cage mates. In: van der Waaij D, Verhoef J, (eds) New criteria for antimicrobial therapy. Excerpta Medica, Amsterdam 43–60
Guiot HFL, van Furth R (1977) Partial antibiotic decontamination. Br Med J 1:800–802
Hughes WT, Kuhn S, Chaudhary S, Feldman S, Verzosa M, Aur RJA, Pratt C, George SL (1977) Successful chemoprophylaxis for pneumocystis carinii pneumonits. N Engl J Med 297:1419–1426
Gurwith MJ, Brunton JL, Lank BA, Harding GKM, Ronald AR (1979) A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 66:248–256
Sleijfer DT, Mulder NH, de Vries-Hospers HG, Fidler V, Nieweg HO, van der Waaij D, van Saene HKF (1980) Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 16:859–869
Guiot HFL, van der Meer J, van Furth R (1981) Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Infect Dis 143:644–654
Wade JC, Schimpff SC, Hargadon MT, Fortner CL, Young VM, Wiernik PH (1981) A comparison of trimethoprimsulfamethoxazole plus nystain with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 304:1057–1062
Dekker AW, Rosenberg-Arska M, Sixma JJ, Verhoef J (1981) Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Int Med 95:555–559
Starke JD, Donnelly P, Catovsky C, Darrell J, Johnson SA, Goldmann JM, Galton DAG (1982) Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukacmia. Lancet I:5–6
Watson JG, Jameson B, Powles RL, McElwain TJ, Lawson DN, Judson J, Morgenstern GR, Lumley H, Kay HEM (1982) Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia. Lancet I:6–9
Bhaduri S, Kurrle E, Krieger D, Pflieger H, Arnold R, Kubanek B, Heimpel H (1982) Infection prophylaxis in acute leukaemia patients: comparison of selective and total antimicrobial decontamination of gastrointestinal tract. Folia Haematol 109:377–389
Gale RP, Cline MJ (1977) High remission induction rate in acute myeloid leukaemia. Lancet I:497–499
Hoelzer D, Löffler H, Thiel E, Bodenstein H, Büchner T, Messerer D, Zwingers T (1982) Multicentric therapy trial for acute lymphatic (ALL) and acute undifferentiated leukaemia (AUL) in adults. Blut 45:218
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patients. II. Analysis and examples. Br J Cancer 35:1–39
Dornbusch K, Toivanen P (1981) Effect of trimethoprim or trimethoprim/sulfamethoxazole usage on the emergence of trimethoprim resistance in urinary tract pathogens. Scand J Infect Dis 13:203–210
Murray BE, Reusimer ER, DuPont HL (1982) Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfmethoxazole. N Engl J Med 306:130–135
Krieger D, Vanek E, Strehle R (1981) Influence of total and selective decontamination on the aerobic and anaerobic gastrointestinal flora in patients with acute leukaemia. In: Sasaki S, Ozawa A, Hashimoto K (eds) Recent advances in germfree research. Tokai University Press, Tokyo, pp 715–718
Author information
Authors and Affiliations
Additional information
Supported by Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 112, Projekt E 1) Presented in part on the “Annual Congress of the Austrian and German Societies of Haematology and Oncology”, October 1982, Innsbruck, Austria
Rights and permissions
About this article
Cite this article
Kurrle, E., Bhaduri, S., Krieger, D. et al. Antimicrobial prophylaxis in acute leukaemia: Prospective randomized study comparing two methods of selective decontamination. Klin Wochenschr 61, 691–698 (1983). https://doi.org/10.1007/BF01487614
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01487614